Hypera Investor Relations Material
Latest events
Q4 2023
Hypera
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Hypera S.A.
Access all reports
Hypera S.A. operates as a pharmaceutical company in Brazil. The company is involved in the production, research and development, marketing, sale and distribution of medicinal products for the treatment of various diseases such as diabetes, asthma, epilepsy and other disorders. Hypera S.A. engages through Pharmaceuticals and Biotechnologies segments. The Pharmaceuticals segment promotes and sells hyperbaric oxygen therapy (HOT) chambers to treat burns; Cortical Stimulation Therapy (CST); foot orthoses; jogging rollers; heart valves, pacemakers and implantable cardioverter defibrillator; the pregnancy test kit, pregnancy urine test kit and ovulation predictors; and iron supplements.
Key slides for Hypera S.A.
Q3 2023
Hypera S.A.
Q4 2023
Hypera S.A.
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇧🇷 Brazil